RECURSION PHARMACEUTICALS, INC. Undistributed Earnings, Diluted
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Undistributed Earnings, Diluted of -$228.27 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Notes › Earnings Per Share
us-gaap:UndistributedEarningsDiluted · last filed 2023-02-27
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for the quarter ending 2022-03-31 was -$53.02M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for the quarter ending 2021-12-31 was -$61.27M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for the quarter ending 2021-09-30 was -$2.66M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for the quarter ending 2021-06-30 was -$2.97M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for fiscal 2022 was -$228.27M.
- RECURSION PHARMACEUTICALS, INC. undistributed earnings, diluted for fiscal 2021 was -$172.40M.
| Period end | Undistributed Earnings, Diluted 3 month | Undistributed Earnings, Diluted 6 month | Undistributed Earnings, Diluted 9 month | Undistributed Earnings, Diluted 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$228.27M 10-K · filed 2023-02-27 | |||
| 2022-03-31 | -$53.02M 10-Q · filed 2022-05-10 | -$114.29M derived: sum of 2 quarters · filed 2023-02-27 | -$116.95M derived: sum of 3 quarters · filed 2023-02-27 | -$119.92M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-12-31 | -$61.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$63.93M derived: sum of 2 quarters · filed 2023-02-27 | -$66.90M derived: sum of 3 quarters · filed 2023-02-27 | -$172.40M 10-K · filed 2023-02-27 |
| 2021-09-30 | -$2.66M 10-Q · filed 2021-11-10 | -$5.63M derived: sum of 2 quarters · filed 2021-11-10 | -$111.13M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$2.97M 10-Q · filed 2021-08-13 | -$65.46M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |